199 related articles for article (PubMed ID: 8154166)
1. [Conservative therapy of peripheral arterial occlusive diseases].
Alexander K
Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up.
Wann-Hansson C; Hallberg IR; Risberg B; Lundell A; Klevsgard R
J Adv Nurs; 2005 Aug; 51(3):227-35. PubMed ID: 16033590
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of peripheral arterial occlusive disease with special reference to prostaglandins].
Creutzig A
Z Gesamte Inn Med; 1991 Mar; 46(3):59-67. PubMed ID: 1828125
[TBL] [Abstract][Full Text] [Related]
4. Outcome criteria in patients with peripheral arterial disease.
Strandness DE; Carter SA
Ann Vasc Surg; 1993 Sep; 7(5):491-6. PubMed ID: 8268098
[TBL] [Abstract][Full Text] [Related]
5. Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
Regensteiner JG; Stewart KJ
Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):604-10. PubMed ID: 17063165
[TBL] [Abstract][Full Text] [Related]
6. Success of an outpatient claudication group training program for patients with peripheral arterial occlusive disease (PAOD): the Tübingen model.
Klyscz T; Jünger M; Jünger I; Hahn M; Rassner G
Cent Eur J Public Health; 1997 Mar; 5(1):13-20. PubMed ID: 9150999
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
[TBL] [Abstract][Full Text] [Related]
8. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
[TBL] [Abstract][Full Text] [Related]
9. [Methods and results of controlled walking training in patients with peripheral arterial occlusive disease].
Cachovan M
Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):626-32. PubMed ID: 10666825
[TBL] [Abstract][Full Text] [Related]
10. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
[No Abstract] [Full Text] [Related]
11. [Therapy of peripheral arterial occlusive diseases. Round table conference].
Bollinger A; Biland L; Brunner U; Kappert A; Krähenbühl B; Mahler F; Monti M; Nachbur B; Schneider E; Widmer LK
Schweiz Med Wochenschr; 1983 Dec; 113(49):1834-6. PubMed ID: 6233698
[No Abstract] [Full Text] [Related]
12. General discussion on therapy in occlusive arterial disease.
Scand J Clin Lab Invest Suppl; 1973; 128():223-7. PubMed ID: 4764587
[No Abstract] [Full Text] [Related]
13. [Physical and exercise therapy in aged patients with peripheral arterial circulatory disorders].
Köhler M
Z Gerontol; 1985; 18(1):17-21. PubMed ID: 4002814
[TBL] [Abstract][Full Text] [Related]
14. Principles of conservative treatment of occlusive arterial disease.
Coffman JD
Cardiovasc Clin; 1983; 13(2):1-13. PubMed ID: 6839316
[TBL] [Abstract][Full Text] [Related]
15. [10 minute consultation: intermittent claudication].
Rieger H
MMW Fortschr Med; 2004 Apr; 146(18):62-3. PubMed ID: 15366482
[No Abstract] [Full Text] [Related]
16. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options.
Rockson SG; Cooke JP
Adv Intern Med; 1998; 43():253-77. PubMed ID: 9506185
[No Abstract] [Full Text] [Related]
17. [Improved microcirculation and collateral circulation in arterial occlusive diseases of the lower extremity].
Sunder-Plassmann L
Fortschr Med; 1981 Nov; 99(43):1813-4. PubMed ID: 7308942
[No Abstract] [Full Text] [Related]
18. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
19. [Methodology in angiologic-therapeutic-clinical research. Inter- and intra-individual comparison in arterial occlusive disease].
Maass U
Fortschr Med; 1983 Oct; 101(40):1831-7. PubMed ID: 6642390
[TBL] [Abstract][Full Text] [Related]
20. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
Leschke M; Schoebel FC; Strauer BE
Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
